·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ¼¿Æ®¸®¿Â, 4064¾ï ±Ô¸ð ½Ã¹Ð·¯ °ø±Þ°è¾à ü°á ±â»çÀÔ·Â : 23.03.29 11:39:21 0 °¡ ÇÃÄ£Ãß°¡ 2021³â ¸ÅÃâ ´ëºñ 21% ±Ô¸ð...·¥½Ã¸¶¡¤Æ®·è½Ã¸¶¡¤ÇãÁ긶 °ø±Þ ¡ãÀÚ°¡¸é¿ªÁúȯ Ä¡·áÁ¦ ·¥½Ã¸¶SC.(»çÁø ¼¿Æ®¸®¿Â) [µ¥Àϸ®ÆÊ=ȲÁøÁß ±âÀÚ] ¼¿Æ®¸®¿ÂÀº ¼¿Æ®¸®¿ÂÇコÄɾî¿Í 4064¾ï¿ø ±Ô¸ð ¹ÙÀÌ¿À½Ã¹Ð·¯ Ç×üÀǾàÇ° °ø±Þ°è¾àÀ» ü°áÇß´Ù°í 29ÀÏ °ø½ÃÇß´Ù. °è¾à±ÝÀº 4063¾ï5000¸¸¿øÀÌ´Ù. °è¾à±ÝÀº ¼¿Æ®¸®¿ÂÀÇ Áö³ 2021³â ¿¬°á ±âÁØ ¸ÅÃâ¾× ´ëºñ 21.26%¿¡ ÇØ´çÇÏ´Â ±Ô¸ð´Ù. À̹ø °è¾àÀ» ÅëÇØ ¼¿Æ®¸®¿ÂÀº ¼¿Æ®¸®¿ÂÇコÄɾ ¹ÙÀÌ¿À½Ã¹Ð·¯ Ç×üÀǾàÇ° ·¥½Ã¸¶IV¿Í Æ®·è½Ã¸¶, ÇãÁ긶, ·¥½Ã¸¶SC¸¦ °ø±ÞÇÑ´Ù. °è¾à±â°£Àº ¿À´Â 31ÀϱîÁö´Ù. ȲÁøÁß ±âÀÚ(jin@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · 'K-¹ÙÀÌ¿À ·¦Çãºê' ÀÎõ ¼Ûµµ¿¡ ±¸Ãà...2726¾ï ÅõÀÔ · K-¹ÙÀÌ¿À½Ã¹Ð·¯ ±Û·Î¹ú Ãâ°Ý 10³â...´©Àû ¼öÃâ¾× 1... · ¼¿Æ®¸®¿Â, Áö´ººê¿Í Ç×ü½Å¾à °³¹ß ÆÄÆ®³Ê½Ê ü°á »ó¹Ý±â ¼ö½Ãä¿ë(°³¹ß±âȹÆÀ/ÀÇÇÐÆÀ/RAÆÀ/Àڱݰø½ÃÆÀ/¿µ¾÷Áö¿øÆÀ) ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â MSL / MI / BD / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±âȹ / ¾à»ç ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â RA/QA ÆÀ¿ø °è¾àÁ÷ ä¿ë ¹Ù·Î°¡±â HK inno.N(ÏÁCJÇコÄɾî) °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] ÀǾàBDÆÀ °æ·ÂÁ÷¿ø ¸ðÁý ¼·ù ÀüÇü (¾à»ç Àû±Ø ¿ì´ë) ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â MSL (Medical Science Liason)_Á¤±ÔÁ÷ ¸ðÁý ¹Ù·Î°¡±â ¸ÞÀÌÀú Á¦¾à»ç Á¦Á¶°ü¸®Ã¥ÀÓÀÚ(ÀÎõ ¼Ûµµ. °æ·Â¹«°ü) ¹Ù·Î°¡±â º¸°ü¼Ò Ç°Áú°ü¸®¾à»ç ¹Ù·Î°¡±â SM(OPH) MSL (À°ÈÞ´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â ¢ß¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾𽺠RA Manager ä¿ë ¹Ù·Î°¡±â ÀǾàÇ°Àç°í ÀÔÃâ°í¹× Àç°í°ü¸®»ç¿ø¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿Æ®¸®¿Â, 4064¾ï ±Ô¸ð ½Ã¹Ð·¯ °ø±Þ°è¾à ü°á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¼¿Æ®¸®¿Â, 4064¾ï ±Ô¸ð ½Ã¹Ð·¯ °ø±Þ°è¾à ü°á ±â»çÀÔ·Â : 23.03.29 11:39:21 0 °¡ ÇÃÄ£Ãß°¡ 2021³â ¸ÅÃâ ´ëºñ 21% ±Ô¸ð...·¥½Ã¸¶¡¤Æ®·è½Ã¸¶¡¤ÇãÁ긶 °ø±Þ ¡ãÀÚ°¡¸é¿ªÁúȯ Ä¡·áÁ¦ ·¥½Ã¸¶SC.(»çÁø ¼¿Æ®¸®¿Â) [µ¥Àϸ®ÆÊ=ȲÁøÁß ±âÀÚ] ¼¿Æ®¸®¿ÂÀº ¼¿Æ®¸®¿ÂÇコÄɾî¿Í 4064¾ï¿ø ±Ô¸ð ¹ÙÀÌ¿À½Ã¹Ð·¯ Ç×üÀǾàÇ° °ø±Þ°è¾àÀ» ü°áÇß´Ù°í 29ÀÏ °ø½ÃÇß´Ù. °è¾à±ÝÀº 4063¾ï5000¸¸¿øÀÌ´Ù. °è¾à±ÝÀº ¼¿Æ®¸®¿ÂÀÇ Áö³ 2021³â ¿¬°á ±âÁØ ¸ÅÃâ¾× ´ëºñ 21.26%¿¡ ÇØ´çÇÏ´Â ±Ô¸ð´Ù. À̹ø °è¾àÀ» ÅëÇØ ¼¿Æ®¸®¿ÂÀº ¼¿Æ®¸®¿ÂÇコÄɾ ¹ÙÀÌ¿À½Ã¹Ð·¯ Ç×üÀǾàÇ° ·¥½Ã¸¶IV¿Í Æ®·è½Ã¸¶, ÇãÁ긶, ·¥½Ã¸¶SC¸¦ °ø±ÞÇÑ´Ù. °è¾à±â°£Àº ¿À´Â 31ÀϱîÁö´Ù. ȲÁøÁß ±âÀÚ(jin@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · 'K-¹ÙÀÌ¿À ·¦Çãºê' ÀÎõ ¼Ûµµ¿¡ ±¸Ãà...2726¾ï ÅõÀÔ · K-¹ÙÀÌ¿À½Ã¹Ð·¯ ±Û·Î¹ú Ãâ°Ý 10³â...´©Àû ¼öÃâ¾× 1... · ¼¿Æ®¸®¿Â, Áö´ººê¿Í Ç×ü½Å¾à °³¹ß ÆÄÆ®³Ê½Ê ü°á »ó¹Ý±â ¼ö½Ãä¿ë(°³¹ß±âȹÆÀ/ÀÇÇÐÆÀ/RAÆÀ/Àڱݰø½ÃÆÀ/¿µ¾÷Áö¿øÆÀ) ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â MSL / MI / BD / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±âȹ / ¾à»ç ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â RA/QA ÆÀ¿ø °è¾àÁ÷ ä¿ë ¹Ù·Î°¡±â HK inno.N(ÏÁCJÇコÄɾî) °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] ÀǾàBDÆÀ °æ·ÂÁ÷¿ø ¸ðÁý ¼·ù ÀüÇü (¾à»ç Àû±Ø ¿ì´ë) ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â MSL (Medical Science Liason)_Á¤±ÔÁ÷ ¸ðÁý ¹Ù·Î°¡±â ¸ÞÀÌÀú Á¦¾à»ç Á¦Á¶°ü¸®Ã¥ÀÓÀÚ(ÀÎõ ¼Ûµµ. °æ·Â¹«°ü) ¹Ù·Î°¡±â º¸°ü¼Ò Ç°Áú°ü¸®¾à»ç ¹Ù·Î°¡±â SM(OPH) MSL (À°ÈÞ´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â ¢ß¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾𽺠RA Manager ä¿ë ¹Ù·Î°¡±â ÀǾàÇ°Àç°í ÀÔÃâ°í¹× Àç°í°ü¸®»ç¿ø¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿Æ®¸®¿Â, 4064¾ï ±Ô¸ð ½Ã¹Ð·¯ °ø±Þ°è¾à ü°á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ¼¿Æ®¸®¿Â, 4064¾ï ±Ô¸ð ½Ã¹Ð·¯ °ø±Þ°è¾à ü°á ±â»çÀÔ·Â : 23.03.29 11:39:21 0 °¡ ÇÃÄ£Ãß°¡ 2021³â ¸ÅÃâ ´ëºñ 21% ±Ô¸ð...·¥½Ã¸¶¡¤Æ®·è½Ã¸¶¡¤ÇãÁ긶 °ø±Þ ¡ãÀÚ°¡¸é¿ªÁúȯ Ä¡·áÁ¦ ·¥½Ã¸¶SC.(»çÁø ¼¿Æ®¸®¿Â) [µ¥Àϸ®ÆÊ=ȲÁøÁß ±âÀÚ] ¼¿Æ®¸®¿ÂÀº ¼¿Æ®¸®¿ÂÇコÄɾî¿Í 4064¾ï¿ø ±Ô¸ð ¹ÙÀÌ¿À½Ã¹Ð·¯ Ç×üÀǾàÇ° °ø±Þ°è¾àÀ» ü°áÇß´Ù°í 29ÀÏ °ø½ÃÇß´Ù. °è¾à±ÝÀº 4063¾ï5000¸¸¿øÀÌ´Ù. °è¾à±ÝÀº ¼¿Æ®¸®¿ÂÀÇ Áö³ 2021³â ¿¬°á ±âÁØ ¸ÅÃâ¾× ´ëºñ 21.26%¿¡ ÇØ´çÇÏ´Â ±Ô¸ð´Ù. À̹ø °è¾àÀ» ÅëÇØ ¼¿Æ®¸®¿ÂÀº ¼¿Æ®¸®¿ÂÇコÄɾ ¹ÙÀÌ¿À½Ã¹Ð·¯ Ç×üÀǾàÇ° ·¥½Ã¸¶IV¿Í Æ®·è½Ã¸¶, ÇãÁ긶, ·¥½Ã¸¶SC¸¦ °ø±ÞÇÑ´Ù. °è¾à±â°£Àº ¿À´Â 31ÀϱîÁö´Ù. ȲÁøÁß ±âÀÚ(jin@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · 'K-¹ÙÀÌ¿À ·¦Çãºê' ÀÎõ ¼Ûµµ¿¡ ±¸Ãà...2726¾ï ÅõÀÔ · K-¹ÙÀÌ¿À½Ã¹Ð·¯ ±Û·Î¹ú Ãâ°Ý 10³â...´©Àû ¼öÃâ¾× 1... · ¼¿Æ®¸®¿Â, Áö´ººê¿Í Ç×ü½Å¾à °³¹ß ÆÄÆ®³Ê½Ê ü°á
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ¼¿Æ®¸®¿Â, 4064¾ï ±Ô¸ð ½Ã¹Ð·¯ °ø±Þ°è¾à ü°á URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö